Ascot PLC
13 March 2000
Contact Howard Dyer, Executive Chairman
Ascot Plc 0207 815 0805
David Bick
Holborn Public Relations 0207 929 5599
david_bick@holbornpr.co.uk
Ascot Plc
Acquisition of Specified Fuels & Chemicals ('Specified')
for $23.5 million (£14.8 million)
KEY POINTS
* Significant increase in chemical custom processing capacity in the growing
US market where Ascot is winning new contracts and requires capacity.
* Ascot is the US market leader for distillation custom processing; Specified
is the US market leader, and Ascot the European market leader, in supplying
research and reference fuels to the automotive, fuel and lubricant
industries.
* The combined businesses make Ascot the world's largest supplier of research
and reference fuels.
* For the year ended 31 December 1999, Specified generated turnover of $26.6
million (£16.8 million) and profit before interest and tax of $3.1 million
(£2.0 million). Net assets acquired, valued as at the same date, are $24.4
million (£15.4 million).
* Purchase price of $23.5 million (£14.8 million) debt free, below net assets,
paid in cash at completion.
* Acquisition is expected to be earnings neutral in the first full year and
earnings enhancing thereafter as the additional capacity is brought on
stream.
Commenting on the acquisition, Howard Dyer, Executive Chairman of Ascot, said
'Following our announcement that we are concentrating the Group's future
activities on the chemicals sector, this acquisition represents an important
opportunity to continue to develop Ascot Speciality Chemicals in the USA.
Specified provides significant additional custom processing capacity
complementing our existing operations in Houston which are fully utilised. It
also provides excellent infrastructure and space for further expansion'.
Ascot Plc has acquired Specified Fuels & Chemicals LLC ('Specified') for a
cash consideration, paid on completion, of $23.5 million (£14.8 million)
slightly below the net asset value of $24.4 million (£15.4 million).
Following completion, the Company will be debt free.
Specified provides major chemical companies with chemical custom manufacturing
services and manufactures research and reference fuels. The company is based
in Houston, Texas, less than one mile from Ascot's own facility.
Ascot's chemical custom processing business in Houston is currently
negotiating with major chemical and petrochemical companies a number of
significant custom processing contracts for which additional capacity is
required. The acquisition of Specified immediately brings that additional
capacity and space available for expansion in a location that is virtually
adjacent to Haltermann's plant and one that, like Haltermann's, has excellent
infrastructure, being accessible by water as well as by road and rail.
In addition to providing much needed additional capacity, Specified is the US
market leader in supplying research and reference fuels which are used in
automotive engine tests for emission and fuel economy certification and for
engine lubrication and fuel research and development. Specified therefore
complements Haltermann Products which is the market leader in research and
reference fuels in Europe, having an estimated 60% share of the market. The
acquisition is expected to bring the benefits of shared research and
technology as well as a complementary customer base.
Funding for the consideration will be met through existing cash resources, and
a new $15 million facility provided by Dresdner Bank AG in London.
Notes to Editors:
Ascot's core business is fine and speciality chemicals. The Speciality
Chemicals and Fine Chemicals divisions, which are together responsible for
approximately 60% of Group turnover and 75% of Group profits, were formed
following the successful acquisition and integration of the Haltermann Group
(acquired by Ascot in December 1998) and ChiroTech (the world leading chiral
technology company acquired by Ascot in September 1998 (30%) and October 1999
(70%)). Ascot Speciality Chemicals is the world's largest independent
chemical custom processor and also manufactures speciality products. Fine
Chemicals comprises ChiroTech and the manufacturing facilities of Mitchell
Cotts Chemicals. The Group also has a number of other operations involved in
engineering and property. As announced on 31 January 2000, Ascot will divest
of its four small engineering businesses and other non-core assets over the
next 18 months. These divestments will enhance the Group's financial ability
to look for acquisitions to complement the Speciality Chemicals and Fine
Chemicals interests and to grow both businesses organically.
Ascot is headquartered in London and employs over 2,000 people world-wide.
The Group has a substantial presence in the UK, Germany, Belgium, Scandinavia
and North America and a broad international customer base for all of its
businesses.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.